Inactivation of the Lipopeptide Antibiotic Daptomycin by Hydrolytic Mechanisms

The lipopeptide daptomycin is a member of the newest FDA-approved antimicrobial class, exhibiting potency against a broad range of Gram-positive pathogens with only rare incidences of clinical resistance. Environmental bacteria harbor an abundance of resistance determinants orthologous to those in p...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: D'Costa, Vanessa M., Mukhtar, Tariq A., Patel, Tejal, Koteva, Kalinka, Waglechner, Nicholas, Hughes, Donald W., Wright, Gerard D., De Pascale, Gianfranco
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2012
Assuntos:
Mechanisms of Resistance
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3264212/
https://ncbi.nlm.nih.gov/pubmed/22083474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05441-11
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares